Adrenoleukodystrophy Newborn Screening in California Since 2016: Programmatic Outcomes and Follow-Up
Open Access
- 17 April 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Neonatal Screening
- Vol. 7 (2), 22
- https://doi.org/10.3390/ijns7020022
Abstract
X-linked adrenoleukodystrophy (ALD) is a recent addition to the Recommended Uniform Screening Panel, prompting many states to begin screening newborns for the disorder. We provide California’s experience with ALD newborn screening, highlighting the clinical and epidemiological outcomes observed as well as program implementation challenges. In this retrospective cohort study, we examine ALD newborn screening results and clinical outcomes for 1,854,631 newborns whose specimens were received by the California Genetic Disease Screening Program from 16 February 2016 through 15 February 2020. In the first four years of ALD newborn screening in California, 355 newborns screened positive for ALD, including 147 (41%) with an ABCD1 variant of uncertain significance (VUS) and 95 males diagnosed with ALD. After modifying cutoffs, we observed an ALD birth prevalence of 1 in 14,397 males. Long-term follow-up identified 14 males with signs of adrenal involvement. This study adds to a growing body of literature reporting on outcomes of newborn screening for ALD and offering a glimpse of what other large newborn screening programs can expect when adding ALD to their screening panel.Keywords
This publication has 35 references indexed in Scilit:
- X-Linked Adrenoleukodystrophy: Molecular and Functional Analysis of the ABCD1 Gene in Argentinean PatientsPLOS ONE, 2012
- X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and managementOrphanet Journal of Rare Diseases, 2012
- Genomic Profiling Identifies Novel Mutations and SNPs in ABCD1 Gene: A Molecular, Biochemical and Clinical Analysis of X-ALD Cases in IndiaPLOS ONE, 2011
- Patients-in-WaitingJournal of Health and Social Behavior, 2010
- Newborn screening for X-linked adrenoleukodystrophy (X-ALD): Validation of a combined liquid chromatography–tandem mass spectrometric (LC–MS/MS) methodMolecular Genetics and Metabolism, 2009
- X-linked adrenoleukodystrophyNature Clinical Practice Neurology, 2007
- Adrenal Insufficiency: Still a Cause of Morbidity and Death in ChildhoodPEDIATRICS, 2007
- Combined liquid chromatography–Tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: Preliminary findingsMolecular Genetics and Metabolism, 2006
- Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screeningThe Journal of Pediatrics, 2005
- ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlationsHuman Mutation, 2001